Once-daily NVA237 improves exercise tolerance from the first dose in patients with COPD: the GLOW3 trial

Por Beeh, Kai M, Singh, Dave, Di Scala, Lilla, Drollmann, Anton
Publicado em 2012

Cardiac safety of indacaterol in healthy subjects: a randomized, multidose, placebo- and positive-controlled, parallel-group thorough QT study

Por Woessner Ralph, Harris Stuart, Sabo Ronald, Khindri Sanjeev, Jennings Simon, Drollmann Anton F
Publicado em 2011-05-01

Cardiac safety of indacaterol in healthy subjects: a randomized, multidose, placebo- and positive-controlled, parallel-group thorough QT study

Por Khindri, Sanjeev, Sabo, Ronald, Harris, Stuart, Woessner, Ralph, Jennings, Simon, Drollmann, Anton F
Publicado em 2011